Total Payments
$39,070
2024 Payments
$134.22
Companies
12
Transactions
69
Medicare Patients
625
Medicare Billing
$78,184
Payment Breakdown by Category
Other$29,095 (74.5%)
Travel$4,121 (10.5%)
Consulting$3,920 (10.0%)
Food & Beverage$1,714 (4.4%)
Education$220.47 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,095 | 7 | 74.5% |
| Travel and Lodging | $4,121 | 12 | 10.5% |
| Consulting Fee | $3,920 | 5 | 10.0% |
| Food and Beverage | $1,714 | 37 | 4.4% |
| Education | $220.47 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $35,508 | 28 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $1,727 | 10 | $0 (2021) |
| Daiichi Sankyo Inc. | $1,327 | 12 | $0 (2017) |
| Janssen Biotech, Inc. | $99.00 | 1 | $0 (2019) |
| Tempus AI, Inc | $96.90 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $76.50 | 2 | $0 (2022) |
| Foundation Medicine, Inc. | $60.22 | 2 | $0 (2023) |
| Celgene Corporation | $52.55 | 5 | $0 (2018) |
| Gilead Sciences, Inc. | $41.62 | 2 | $0 (2021) |
| Genentech, Inc. | $37.32 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.22 | 4 | Tempus AI, Inc ($96.90) |
| 2023 | $60.22 | 2 | Foundation Medicine, Inc. ($60.22) |
| 2022 | $57.00 | 1 | GlaxoSmithKline, LLC. ($57.00) |
| 2021 | $10,107 | 13 | E.R. Squibb & Sons, L.L.C. ($10,048) |
| 2020 | $64.95 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($28.50) |
| 2019 | $14,893 | 13 | E.R. Squibb & Sons, L.L.C. ($14,778) |
| 2018 | $12,427 | 20 | E.R. Squibb & Sons, L.L.C. ($10,665) |
| 2017 | $1,327 | 12 | Daiichi Sankyo Inc. ($1,327) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $33.22 | General |
| 09/20/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $30.60 | General |
| 05/22/2024 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $37.32 | General |
| 05/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $33.08 | General |
| 09/27/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/01/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $20.22 | General |
| 09/13/2022 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Education | In-kind items and services | $57.00 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $26.27 | General |
| Category: Oncology | ||||||
| 11/19/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $946.00 | General |
| 10/25/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 10/20/2021 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 10/05/2021 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,310.00 | General |
| 10/05/2021 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,645.00 | General |
| 10/04/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 09/23/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $120.55 | General |
| 07/19/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: Oncology | ||||||
| 07/15/2021 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: ONC | ||||||
| 06/11/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,773.75 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/05/2021 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 09/03/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Oncology | ||||||
| 08/20/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar, Vitrakvi | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Oncology | ||||||
| 08/07/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| 08/28/2019 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 54 | 74 | $11,451 | $2,293 |
| 2021 | 8 | 335 | 644 | $131,676 | $49,608 |
| 2020 | 6 | 236 | 389 | $89,424 | $26,283 |
Total Patients
625
Total Services
1,107
Medicare Billing
$78,184
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 27 | $5,852 | $1,138 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 32 | $4,541 | $1,031 | 22.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $1,057 | $124.86 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 302 | $64,658 | $24,708 | 38.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 78 | $23,587 | $9,214 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 133 | $18,514 | $7,082 | 38.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $14,685 | $4,916 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,568 | $1,457 | 31.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 36 | 45 | $3,155 | $1,403 | 44.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 13 | $1,810 | $609.16 | 33.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 26 | 28 | $700.00 | $218.40 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 134 | $26,573 | $8,746 | 32.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 69 | $19,392 | $6,678 | 34.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 20 | 20 | $8,526 | $2,874 | 33.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 37 | 75 | $16,082 | $2,549 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 28 | $8,336 | $1,795 | 21.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,476 | $1,793 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 32 | $4,200 | $1,351 | 32.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 13 | 14 | $840.00 | $497.90 | 59.3% |
About Jason Lukas, MD, PHD
Jason Lukas, MD, PHD is a Hematology & Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427204262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jason Lukas, MD, PHD has received a total of $39,070 in payments from pharmaceutical and medical device companies, with $134.22 received in 2024. These payments were reported across 69 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,095).
As a Medicare-enrolled provider, Lukas has provided services to 625 Medicare beneficiaries, totaling 1,107 services with total Medicare billing of $78,184. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Seattle, WA
- Active Since 08/12/2008
- Last Updated 02/13/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427204262
Products in Payments
- OPDIVO (Biological) $20,439
- EMPLICITI (Biological) $5,057
- KEYTRUDA (Biological) $1,709
- IMBRUVICA (Drug) $99.00
- JEMPERLI (Biological) $57.00
- Trodelvy (Drug) $29.70
- Stivarga (Drug) $28.50
- ZEJULA (Drug) $19.50
- Perjeta (Biological) $15.72
- Revlimid (Drug) $10.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Seattle
Mr. John Pesando, Md, MD
Hematology & Oncology — Payments: $12.8M
Hematology & Oncology $12.8M
John Pagel, Md Phd, MD PHD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Langdon Miller, Md, MD
Hematology & Oncology — Payments: $674,815
Hematology & Oncology $674,815
Dr. Vijayakrishna Gadi, M.d. Phd, M.D. PHD
Hematology & Oncology — Payments: $534,649
Hematology & Oncology $534,649
Barbara Konkle, Md, MD
Hematology & Oncology — Payments: $331,390
Hematology & Oncology $331,390
Dr. Jill Johnsen, Md, MD
Hematology & Oncology — Payments: $291,732
Hematology & Oncology $291,732